MARKET

ENSC

ENSC

Ensysce Biosciences Inc
NASDAQ
0.2928
-0.0081
-2.69%
Opening 09:40 06/29 EDT
OPEN
0.3000
PREV CLOSE
0.3009
HIGH
0.3013
LOW
0.2900
VOLUME
133.62K
TURNOVER
--
52 WEEK HIGH
2.750
52 WEEK LOW
0.2300
MARKET CAP
4.50M
P/E (TTM)
-0.0876
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ENSC last week (0622-0626)?
Weekly Report · 7h ago
Ensysce Biosciences enrolls first patient in final stage of PF614-MPAR-102
TipRanks · 3d ago
Ensysce Biosciences Initiates Final State Of Its PF614-MPAR-102 Clinical Trial To Evaluate Multi-Pill Abuse Resistance Overdose-Protection Technology
Benzinga · 3d ago
Ensysce enrolls first patient in final phase of PF614-MPAR-102 overdose-protection trial
PUBT · 3d ago
Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
Barchart · 3d ago
Weekly Report: what happened at ENSC last week (0615-0619)?
Weekly Report · 06/22 10:40
Weekly Report: what happened at ENSC last week (0608-0612)?
Weekly Report · 06/15 10:40
Weekly Report: what happened at ENSC last week (0601-0605)?
Weekly Report · 06/08 10:35
More
About ENSC
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.

Webull offers Ensysce Biosciences Inc stock information, including NASDAQ: ENSC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENSC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENSC stock methods without spending real money on the virtual paper trading platform.